3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
7
Neuroendocrine Tumors
2
Multiple Myeloma
2
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lymphoma
1
Liver Cirrhosis
1
Hepatitis C
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Interventions
Radiotherapy
3
Pyridoxine
2
Etoposide
2
Epoetin Alfa
2
Cisplatin
2
Capecitabine
2
uridine triacetate
1
peginterferon alfa-2b
1
pegaspargase
1
Vincristine
1
Pyridostigmine Bromide
1
Prednisolone
1
Paclitaxel
1
Oxaliplatin
1
Octreotide
1
Methylprednisolone
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Laparoscopy
1
Introns
1
Hydrocortisone
1
Gemcitabine
1
Furosemide
1
Fluorouracil
1
Filgrastim
1
Erythropoietin
1
Duloxetine Hydrochloride
1
Doxorubicin
1
Dexrazoxane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Drug-Related Side Effects and Adverse Reactions
×
Introns
×
Clear all
NCT00221702
2010-10-13
EADO
University Hospital, Bordeaux
Phase 3
Completed
898 enrolled